Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis

Logan Banadyga, Michael A. Dolan, Hideki Ebihara

Research output: Contribution to journalReview article

22 Citations (Scopus)

Abstract

Ebola, Marburg, and Ravn viruses, all filoviruses, are the causative agents of severe hemorrhagic fever. Much of what we understand about the pathogenesis of filovirus disease is derived from work with animal models, including nonhuman primates, which are considered the “gold standard” filovirus model since they faithfully recapitulate the clinical hallmarks of filovirus disease. However, rodent models, including the mouse, guinea pig, and hamster, also exist for Ebola, Marburg, and Ravn viruses, and although they may not reproduce all the clinical signs of filovirus disease, thanks to their relative ease of use and low cost, they are often the first choice for initial descriptions of virus pathogenesis and evaluation of antiviral prophylactics and therapeutics. Since filoviruses do not cause significant disease in adult, immunocompetent rodents, these models rely on “rodent-adapted” viruses that have been passaged several times through their host until virulence and lethality are achieved. In the process of adaptation, the viruses acquire numerous nucleotide/amino acid mutations that contribute to virulence in their rodent host. Interestingly, virus protein 24 (VP24) and nucleoprotein (NP) appear to be major virulence factors for ebolaviruses in rodents, whereas VP40 appears to be the major virulence factor for marburgviruses. By characterizing these mutations and understanding the molecular mechanisms that lead to the acquisition of virulence, we can gain better insight into the pathogenic processes that underlie filovirus disease in humans. These processes, and the viral and/or cellular proteins that contribute to them, will make attractive targets for the development of novel therapeutics and counter-measures.

Original languageEnglish (US)
Pages (from-to)3449-3466
Number of pages18
JournalJournal of Molecular Biology
Volume428
Issue number17
DOIs
StatePublished - Aug 28 2016
Externally publishedYes

Fingerprint

Marburgvirus
Rodentia
Viruses
Virulence
Virulence Factors
Ebolavirus
Mutation
Nucleoproteins
Cricetinae
Primates
Antiviral Agents
Guinea Pigs
Proteins
Fever
Nucleotides
Animal Models
Amino Acids
Costs and Cost Analysis
Therapeutics

Keywords

  • Ebola virus
  • Filovirus
  • Marburg virus
  • pathogenesis
  • rodent adaptation

ASJC Scopus subject areas

  • Molecular Biology

Cite this

Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis. / Banadyga, Logan; Dolan, Michael A.; Ebihara, Hideki.

In: Journal of Molecular Biology, Vol. 428, No. 17, 28.08.2016, p. 3449-3466.

Research output: Contribution to journalReview article

Banadyga, Logan ; Dolan, Michael A. ; Ebihara, Hideki. / Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis. In: Journal of Molecular Biology. 2016 ; Vol. 428, No. 17. pp. 3449-3466.
@article{a5b836a6b42648c5bd838aff46ea9022,
title = "Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis",
abstract = "Ebola, Marburg, and Ravn viruses, all filoviruses, are the causative agents of severe hemorrhagic fever. Much of what we understand about the pathogenesis of filovirus disease is derived from work with animal models, including nonhuman primates, which are considered the “gold standard” filovirus model since they faithfully recapitulate the clinical hallmarks of filovirus disease. However, rodent models, including the mouse, guinea pig, and hamster, also exist for Ebola, Marburg, and Ravn viruses, and although they may not reproduce all the clinical signs of filovirus disease, thanks to their relative ease of use and low cost, they are often the first choice for initial descriptions of virus pathogenesis and evaluation of antiviral prophylactics and therapeutics. Since filoviruses do not cause significant disease in adult, immunocompetent rodents, these models rely on “rodent-adapted” viruses that have been passaged several times through their host until virulence and lethality are achieved. In the process of adaptation, the viruses acquire numerous nucleotide/amino acid mutations that contribute to virulence in their rodent host. Interestingly, virus protein 24 (VP24) and nucleoprotein (NP) appear to be major virulence factors for ebolaviruses in rodents, whereas VP40 appears to be the major virulence factor for marburgviruses. By characterizing these mutations and understanding the molecular mechanisms that lead to the acquisition of virulence, we can gain better insight into the pathogenic processes that underlie filovirus disease in humans. These processes, and the viral and/or cellular proteins that contribute to them, will make attractive targets for the development of novel therapeutics and counter-measures.",
keywords = "Ebola virus, Filovirus, Marburg virus, pathogenesis, rodent adaptation",
author = "Logan Banadyga and Dolan, {Michael A.} and Hideki Ebihara",
year = "2016",
month = "8",
day = "28",
doi = "10.1016/j.jmb.2016.05.008",
language = "English (US)",
volume = "428",
pages = "3449--3466",
journal = "Journal of Molecular Biology",
issn = "0022-2836",
publisher = "Academic Press Inc.",
number = "17",

}

TY - JOUR

T1 - Rodent-Adapted Filoviruses and the Molecular Basis of Pathogenesis

AU - Banadyga, Logan

AU - Dolan, Michael A.

AU - Ebihara, Hideki

PY - 2016/8/28

Y1 - 2016/8/28

N2 - Ebola, Marburg, and Ravn viruses, all filoviruses, are the causative agents of severe hemorrhagic fever. Much of what we understand about the pathogenesis of filovirus disease is derived from work with animal models, including nonhuman primates, which are considered the “gold standard” filovirus model since they faithfully recapitulate the clinical hallmarks of filovirus disease. However, rodent models, including the mouse, guinea pig, and hamster, also exist for Ebola, Marburg, and Ravn viruses, and although they may not reproduce all the clinical signs of filovirus disease, thanks to their relative ease of use and low cost, they are often the first choice for initial descriptions of virus pathogenesis and evaluation of antiviral prophylactics and therapeutics. Since filoviruses do not cause significant disease in adult, immunocompetent rodents, these models rely on “rodent-adapted” viruses that have been passaged several times through their host until virulence and lethality are achieved. In the process of adaptation, the viruses acquire numerous nucleotide/amino acid mutations that contribute to virulence in their rodent host. Interestingly, virus protein 24 (VP24) and nucleoprotein (NP) appear to be major virulence factors for ebolaviruses in rodents, whereas VP40 appears to be the major virulence factor for marburgviruses. By characterizing these mutations and understanding the molecular mechanisms that lead to the acquisition of virulence, we can gain better insight into the pathogenic processes that underlie filovirus disease in humans. These processes, and the viral and/or cellular proteins that contribute to them, will make attractive targets for the development of novel therapeutics and counter-measures.

AB - Ebola, Marburg, and Ravn viruses, all filoviruses, are the causative agents of severe hemorrhagic fever. Much of what we understand about the pathogenesis of filovirus disease is derived from work with animal models, including nonhuman primates, which are considered the “gold standard” filovirus model since they faithfully recapitulate the clinical hallmarks of filovirus disease. However, rodent models, including the mouse, guinea pig, and hamster, also exist for Ebola, Marburg, and Ravn viruses, and although they may not reproduce all the clinical signs of filovirus disease, thanks to their relative ease of use and low cost, they are often the first choice for initial descriptions of virus pathogenesis and evaluation of antiviral prophylactics and therapeutics. Since filoviruses do not cause significant disease in adult, immunocompetent rodents, these models rely on “rodent-adapted” viruses that have been passaged several times through their host until virulence and lethality are achieved. In the process of adaptation, the viruses acquire numerous nucleotide/amino acid mutations that contribute to virulence in their rodent host. Interestingly, virus protein 24 (VP24) and nucleoprotein (NP) appear to be major virulence factors for ebolaviruses in rodents, whereas VP40 appears to be the major virulence factor for marburgviruses. By characterizing these mutations and understanding the molecular mechanisms that lead to the acquisition of virulence, we can gain better insight into the pathogenic processes that underlie filovirus disease in humans. These processes, and the viral and/or cellular proteins that contribute to them, will make attractive targets for the development of novel therapeutics and counter-measures.

KW - Ebola virus

KW - Filovirus

KW - Marburg virus

KW - pathogenesis

KW - rodent adaptation

UR - http://www.scopus.com/inward/record.url?scp=84970029049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84970029049&partnerID=8YFLogxK

U2 - 10.1016/j.jmb.2016.05.008

DO - 10.1016/j.jmb.2016.05.008

M3 - Review article

C2 - 27189922

AN - SCOPUS:84970029049

VL - 428

SP - 3449

EP - 3466

JO - Journal of Molecular Biology

JF - Journal of Molecular Biology

SN - 0022-2836

IS - 17

ER -